First ‘Made in India’ cervical cancer vaccine in offing
Vaccine to be launched after adequate doses manufactured for distribution
Are COVID-19 boosters ethical, with half the world waiting for a first shot? A bioethicist weighs in
It’s unfair for richer countries to use up more of global vaccine supply while 58% of people in the world have not received their first …
COVID-19 vaccine hesitancy worries Centre, appeals beneficiaries to shun it
‘Covaxin recipients being followed-up with phone calls, Covishield’s have to report adverse events on their own’
Haphazard COVID-19 vaccine donations useless for Africa, WHO flags
Countries should be informed 4 weeks in advance, shots should have at least 10-month shelf-life
Kenya’s COVID-19 vaccine rollout has got off to a slow start: The gaps, and how to fix them
Kenya is currently accessing vaccines exclusively through the COVAX facility, and yet supply to this initiative has been dogged by vaccine …
COVID-19 vaccine update: AstraZeneca vaccinations should continue, benefits outweigh risks, says WHO
Strategic advisory group of experts on immunization called the one-dose Janssen shot as a safe and lifesaving addition to Pfizer, Moderna and …
COVID-19 vaccine update: South Africa may return Serum Institute of India doses
The WHO has approved the Oxford-AstraZeneca coronavirus jab for emergency use. This means the vaccine can be rolled out globally
Simply put: A billion vaccines
How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakers
Compulsory licensing might be the answer
Measles outbreak in Mumbai: 164 cases reported since September
Measles is a highly contagious viral infection associated with high mortality in children under 2 years
Why Africa’s push to make vaccines should look further than COVID-19
Africa’s segmented markets, and often small economies, are at odds with the fact that vaccines are mostly produced in large quantities to …
COVID-19 vaccines: What the world needs & what we have
While 168 countries are currently administering COVID-19 vaccines, the distribution remains skewed
Nigeria at sixes and sevens on COVID-19 vaccine rollout
Nigeria plans to vaccinate 40% of its citizens before end of 2021 and 70% by end of 2022
Scientists propose Controlled Human Infection Model studies
In CHIM, researchers infect healthy participants with a weakened strain of a pathogen in a controlled setting to learn more about the infection …
Anti-vaccine poster boy: Is Andrew Wakefield the most hated man in modern medicine?
Anti-vaccine 'hero' Andrew Wakefield was stripped of medical credentials in '98. Now his film has been pulled from Tribeca film festival
Protection against COVID-19 infection, severe disease falls quickly after AstraZeneca 2nd dose: Lancet
Begins to wane after 18-19 weeks; study stresses on need for booster dose
Infographic: Do we need a booster dose?
Omicron, the most common COVID-19 strain in the world today, has dramatically reduced the efficacy and duration of vaccine protection
COVID-19 vaccines for all: Decoding global tenders by states
At least a dozen Indian states have floated or will float tenders for procuring vaccines and will also bear the cost
COVID-19 vaccines: How Pfizer and Moderna’s 95% effective mRNA shots work
Should we expect the pandemic to be over once a vaccine is available for public use? Not exactly. A vaccine will not be perfect, and it takes …
COVID-19: A global survey shows worrying signs of vaccine hesitancy
Only 46.3% of Nigerians said they would accept a COVID-19 vaccine. This was slightly higher than the results found in Spain, Sweden, …
A promise of equitable access to all
WHO, pharma giants and governments have come together to provide access to all on COVID-19 therapies. But will WIPO allow this to happen?
Lateral Thoughts: A paradigm change in clinical trials
The rich and famous are clamouring to get the ‘experimental’ COVID-19 vaccine
The ‘kraken’ COVID variant XBB.1.5 is rising quickly in the US — here’s what it could mean for the UK
While XBB’s mutations enable it to evade our immune systems better than previous omicron subvariants, it doesn’t appear to be causing&…
China’s definition of COVID deaths ‘very narrow’, country’s data ‘under-represents’ severity: WHO
Updated definition is narrow since it counts only those deaths caused by COVID-induced pneumonia or respiratory failures
Lifecycle of COVID-19: Yet another omicron sub-variant has countries on high alert
XBB.1.5 shows how dynamic and wide-reaching SARS-CoV-2 variant evolution is, says expert